During early postnatal development of the CNS, neuronal networks are configured through
the formation, elimination, and remodeling of dendritic spines, the sites of most excitatory …

Chondroitin sulfate proteoglycans (CSPGs) are a family of extracellular matrix molecules
with various functions in regulating tissue morphogenesis, cell division, and axon guidance …

The current dogma in neural regeneration research implies that chondroitin sulfate
proteoglycans (CSPGs) inhibit plasticity and regeneration in the adult central nervous …

Chondroitin sulfate proteoglycans are the principal inhibitory component of glial scars, which
form after damage to the adult central nervous system and act as a barrier to regenerating …

Chondroitin sulfate proteoglycans (CSPGs) are up‐regulated following spinal cord injury
and are partly responsible for failed regeneration. Experimental paradigms in vivo that …

Growth-inhibitory chondroitin sulfate proteoglycans (CSPG) are a primary target for
therapeutic strategies after spinal cord injury because of their contribution to the inhibitory …

Chondroitin sulfate proteoglycan (CSPG) inhibits outgrowth from embryonic chick and
rodent neurons in vivo and in vitro and is upregulated during development and following …

DSD-1-PG is a chondroitin sulfate proteoglycan (CSPG) expressed by glial cells that can
promote neurite outgrowth from rat embryonic mesencephalic (E14) and hippocampal (E18) …

Spinal cord injury (SCI) causes permanent debilitation due to the inability of axons to grow
through established scars. Both the sugar chains and core proteins of chondroitin sulfate …

The expression of chondroitin sulfate proteoglycans (CSPGs) by reactive astrocytes is a
major factor contributing to glial scarring and regenerative failure after spinal cord injury, but …